share_log

Goldman Sachs Maintains Buy on Cue Health, Lowers Price Target to $3

Benzinga ·  May 1, 2023 08:27

Goldman Sachs analyst Matthew Sykes maintains Cue Health (NASDAQ:HLTH) with a Buy and lowers the price target from $3.5 to $3.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment